Advanced search
Publication Cover
Acta Oncologica Volume 27, 1988 - Issue 6
Journal homepage
546
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Weekly Low-Dose Doxorubicin as Second Line Therapy in Advanced Breast Cancer

I. Elomaa From the Department of Radiotherapy and Oncology, University of Helsinki, SF-00290, Helsinki, Finland
,
C. Blomqvist From the Department of Radiotherapy and Oncology, University of Helsinki, SF-00290, Helsinki, Finland
&
P. Rissanen From the Department of Radiotherapy and Oncology, University of Helsinki, SF-00290, Helsinki, Finland
Pages 799-801 | Published online: 07 Aug 2009

References

  • Brambilla C., DeLena M., Rossi A., Valagussa P., Bonadonna G. Response and survival in advanced breast cancer after two non-cross-resistant combinations. Br. Med. J. 1976; 1: 801
  • Chlebowski R. T., Paroly W. S., Pugh R. P., et al. Adriamycin given as a weekly schedule without a loading course: Clinically effective with reduced incidence of cardiotoxicity. Cancer Treat. Rep. 1980; 64: 47
  • Gottlieb J., Rivkin S., Spigel S., et al. Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. Cancer 1974; 33: 519
  • Greech R. H., Catalano R. B., Shah M. K. An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patients. Cancer 1980; 46: 433
  • Gundersen S., Kvinnsland S., Klapp O., Kvaløy S., Lund E., Host H. Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial. Eur. J. Cancer Clin. Oncol. 1986; 22: 1431
  • Hoogstraten B., George S., Samal B., et al. Combination chemotherapy and adriamycin in patients with advanced breast cancer—a Southwest Oncology Group study. Cancer 1976; 38: 13
  • Nemoto T., Rosner D., Diaz R., et al. Combination chemotherapy for metastatic breast cancer; comparison of multiple drug therapy with 5-fluorouracil, Cytoxan and prednisone with adriamycin or adrenalectomy. Cancer 1978; 41: 2073
  • O'Bryan R., Baker L., Gottlieb J., et al. Dose response evaluation of adriamycin in human neoplasia. Cancer 1977; 39: 1940
  • Scheithauer W., Zielinski C., Ludwig H. Weekly low-dose cytotoxic monotherapy in metastatic breast cancer resistant to previous hormonal and cytostatic treatment. Breast Cancer Res. Treat. 1985; 6: 89
  • Sigurdsson H., Johansson-Terje I., Aspegren K., et al. Weekly-dose doxorubicin (WDA) in advanced breast cancer. Radiother. Oncol. 1986; 7: 133
  • Tormey D. C. Adriamycin (NSC-123127) in breast cancer: An overview of studies. Cancer Chemother. Rep. 1975; 6: 319
  • Weiss A. J., Metter G. E., Fletcher W. S., Wilson W. L., Grage T. B., Ramirez G. Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. Cancer Treat. Rep. 1976; 60: 813

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.